Robin Feldman

UC Law, San Francisco

Arthur J. Goldberg Distinguished Professor of Law and the Director of the Center for Innovation

200 McAllister Street

San Francisco, CA 94102

United States

http://https://www.uchastings.edu/people/robin-feldman/

SCHOLARLY PAPERS

74

DOWNLOADS
Rank 1,583

SSRN RANKINGS

Top 1,583

in Total Papers Downloads

31,759

SSRN CITATIONS
Rank 11,365

SSRN RANKINGS

Top 11,365

in Total Papers Citations

75

CROSSREF CITATIONS

55

Scholarly Papers (74)

1.

Do Patent Licensing Demands Mean Innovation?

101 Iowa Law Review 137 (2015), Stanford Law and Economics Olin Working Paper No. 473, Stanford Public Law Working Paper No. 2565292, UC Hastings Research Paper No. 135
Number of pages: 53 Posted: 16 Feb 2015 Last Revised: 23 Apr 2020
Robin Feldman and Mark A. Lemley
UC Law, San Francisco and Stanford Law School
Downloads 2,665 (8,881)
Citation 17

Abstract:

Loading...

patent, patents, troll, trolls, trolling, innovation, empirical, intellectual property

2.

The AIA 500 Expanded: The Effects of Patent Monetization Entities

UC Hastings Research Paper No. 45
Number of pages: 138 Posted: 09 Apr 2013 Last Revised: 31 Jan 2014
Robin Feldman, Thomas Ewing and Sara Jeruss
UC Law, San Francisco, Avancept LLC and Lex Machina Inc.
Downloads 2,383 (10,662)
Citation 7

Abstract:

Loading...

patent, patents, patent troll, patent trolls, NPE, NPEs, non-practicing entities, intellectual property, empirical, antitrust

3.

May Your Drug Price Be Evergreen

Oxford Journal of Law and the Biosciences (2018)
Number of pages: 58 Posted: 31 Oct 2017 Last Revised: 28 Apr 2019
Robin Feldman
UC Law, San Francisco
Downloads 2,085 (13,221)
Citation 5

Abstract:

Loading...

Patent, Patents, Intellectual Property, Pharmaceuticals, Pharma, Generics, Competition, Drug, Drugs, Exclusivities, FDA

4.

The America Invents Act 500: Effects of Patent Monetization Entities on US Litigation

11 Duke Law & Technology Review 357, 2012, UC Hastings Research Paper No. 3
Number of pages: 34 Posted: 08 Oct 2012 Last Revised: 12 Mar 2013
Sara Jeruss, Robin Feldman and Joshua H. Walker
Lex Machina Inc., UC Law, San Francisco and Simpson Thacher & Bartlett LLP
Downloads 2,005 (14,056)
Citation 1

Abstract:

Loading...

patent, trolls, non-practicing entities, NPE, patent assertion entities, PAE, America Invents Act, AIA, patent reform

Patent Demands & Startup Companies: The View from the Venture Capital Community

UC Hastings Research Paper No. 75
Number of pages: 72 Posted: 28 Oct 2013 Last Revised: 14 Mar 2015
Robin Feldman
UC Law, San Francisco
Downloads 1,316 (26,295)
Citation 11

Abstract:

Loading...

patent, patent troll, intellectual property, startups, venture capital

Patent Demands & Startup Companies: The View from the Venture Capital Community

16 YALE J.L. & TECH. 236 (2014), UC Hastings Research Paper No. 137
Number of pages: 50 Posted: 07 Feb 2015 Last Revised: 27 Mar 2015
Robin Feldman
UC Law, San Francisco
Downloads 205 (253,289)
Citation 7

Abstract:

Loading...

6.

Coming of Age for the Federal Circuit

The Green Bag, Forthcoming, UC Hastings Research Paper No. 119
Number of pages: 18 Posted: 16 Sep 2014 Last Revised: 04 Dec 2014
Robin Feldman
UC Law, San Francisco
Downloads 1,131 (33,358)

Abstract:

Loading...

7.

Open Letter on Ethical Norms in Intellectual Property Scholarship

Stanford Public Law Working Paper No. 2714416, Duke I&E Research Paper No. 16-7, Duke Law School Public Law & Legal Theory Series No. 2016-9, 29 Harvard Journal of Law and Technology 339 (2016)
Number of pages: 14 Posted: 13 Jan 2016 Last Revised: 23 Apr 2020
UC Law, San Francisco, Stanford Law School, University of Chicago - Law School and Duke University School of Law
Downloads 1,087 (35,245)
Citation 1

Abstract:

Loading...

8.

Drug Wars: A New Generation of Generic Pharmaceutical Delay

Harvard Journal on Legislation, Vol. 53, 2016, UC Hastings Research Paper No. 155
Number of pages: 64 Posted: 11 Sep 2015 Last Revised: 20 Jun 2016
Robin Feldman and Evan Frondorf
UC Law, San Francisco and University of California Hastings College of the Law
Downloads 1,087 (35,245)
Citation 1

Abstract:

Loading...

generic pharmaceuticals, pay-for-delay, antitrust, reverse payment, generic delay

9.

Patent Licensing, Technology Transfer, & Innovation

Stanford Law and Economics Olin Working Paper No. 484
Number of pages: 23 Posted: 28 Feb 2016 Last Revised: 01 Mar 2016
Mark A. Lemley and Robin Feldman
Stanford Law School and UC Law, San Francisco
Downloads 1,058 (36,673)
Citation 6

Abstract:

Loading...

10.

The Open Source Biotechnology Movement: Is it Patent Misuse?

Number of pages: 51 Posted: 11 May 2004
Robin Feldman
UC Law, San Francisco
Downloads 1,054 (36,901)
Citation 11

Abstract:

Loading...

Open source, biotechnology, patent misuse, patents

11.

Patent Trolling — Why Bio & Pharmaceuticals Are at Risk

17 Stan. Tech. L. Rev. 773, 2014, UC Hastings Research Paper No. 93
Number of pages: 40 Posted: 15 Feb 2014 Last Revised: 03 Apr 2016
Robin Feldman and W. Nicholson Price II
UC Law, San Francisco and University of Michigan Law School
Downloads 1,007 (39,420)
Citation 5

Abstract:

Loading...

nonpracticing entities, patent trolls, patent assertion entities, pharmaceuticals, patents, biotechnology

12.

The Giants Among Us

Stanford Technology Law Review, Vol. 1, 2012
Number of pages: 63 Posted: 08 Sep 2011 Last Revised: 13 Nov 2012
Robin Feldman and Thomas Ewing
UC Law, San Francisco and Avancept LLC
Downloads 881 (47,369)
Citation 7

Abstract:

Loading...

patent, intellectual property, troll, patent troll, trolls, patent trolls, anticompetitive, non-practicing entity, NPE, IP, Antitrust

13.

Whose Body is it Anyway? Human Cells and the Strange Effects of Property and Intellectual Property Law

Stanford Law Review, Forthcoming
Number of pages: 37 Posted: 28 Dec 2010
Robin Feldman
UC Law, San Francisco
Downloads 722 (62,004)

Abstract:

Loading...

Intellectual Property, Patent, Patents, Real Property, Land, Gene Patents, Genes, Bilski, Myriad, Association for Molecular Pathology, Biotech, Biotechnology, Life Science, Genetic Patents, Molecules

14.

Perverse Incentives: Why Everyone Prefers High Drug Prices -- Except for Those Who Pay the Bills

57 Harv. J. on Legis. 303 (2020)
Number of pages: 74 Posted: 18 Apr 2018 Last Revised: 21 Oct 2020
Robin Feldman
UC Law, San Francisco
Downloads 648 (71,306)
Citation 2

Abstract:

Loading...

15.

The Insufficiency of Antitrust Analysis for Patent Misuse

Number of pages: 51 Posted: 03 Feb 2004
Robin Feldman
UC Law, San Francisco
Downloads 635 (73,162)

Abstract:

Loading...

Intellectual property, patent, patent misuse, antitrust, reach-through royalties, reach-through, reach through royalties, reach through

16.

Artificial Intelligence: The Importance of Trust & Distrust

Green Bag, Vol. 21, no. 3 (2018)
Number of pages: 13 Posted: 16 Feb 2018 Last Revised: 28 Apr 2019
Robin Feldman
UC Law, San Francisco
Downloads 507 (96,723)

Abstract:

Loading...

Artificial Intelligence

17.

Consumption Taxes and the Theory of General and Individual Taxation

Number of pages: 69 Posted: 28 Aug 2001
Robin Feldman
UC Law, San Francisco
Downloads 504 (97,401)
Citation 1

Abstract:

Loading...

18.

Patent and Antitrust: Differing Shades of Meaning

Virginia Journal of Law and Technology, Vol. 13, No. 2, 2008
Number of pages: 19 Posted: 02 May 2008
Robin Feldman
UC Law, San Francisco
Downloads 460 (108,728)

Abstract:

Loading...

patent,antitrust, biotechnology, biotech, generic, pharmaceutical, monopoly

19.

Empirical Evidence of Drug Pricing Games - A Citizen's Pathway Gone Astray

20 Stan. Tech. L. Rev. 39 (2017), UC Hastings Research Paper No. 215
Number of pages: 53 Posted: 02 Sep 2016 Last Revised: 23 May 2017
UC Law, San Francisco, University of California Hastings College of the Law, UC Law, San Francisco and University of California, Hastings College of the Law, Students
Downloads 450 (111,495)

Abstract:

Loading...

patent, pharmaceutical, pharmaceuticals, citizen petitions, Hatch-Waxman, FDA, drug prices, antitrust, drug pricing, health

20.

Intellectual Property Wrongs

Stanford Journal of Law, Business, and Finance, Forthcoming, UC Hastings Research Paper No. 32
Number of pages: 70 Posted: 11 Aug 2012 Last Revised: 11 Oct 2015
Robin Feldman
UC Law, San Francisco
Downloads 431 (117,655)
Citation 2

Abstract:

Loading...

intellectual property, patent, copyright, trade secret, antitrust

21.

Regulatory Property: The New IP

40 Colum. J.L. & Arts 53 (2016)
Number of pages: 67 Posted: 30 Jul 2016 Last Revised: 21 Oct 2020
Robin Feldman
UC Law, San Francisco
Downloads 416 (122,623)

Abstract:

Loading...

patents, intellectual property, healthcare, pharmaceuticals, generics, exclusivities

22.

The Price Tag of 'Pay-for-Delay'

UC Hastings Research Paper Forthcoming
Number of pages: 53 Posted: 18 May 2021 Last Revised: 27 Aug 2021
Robin Feldman
UC Law, San Francisco
Downloads 402 (127,200)

Abstract:

Loading...

anticompetitive, antitrust, pay-for-delay, patent settlement, reverse payment

23.

Atomistic Antitrust

UC Hastings Research Paper Forthcoming
Number of pages: 80 Posted: 26 Feb 2021
Mark A. Lemley and Robin Feldman
Stanford Law School and UC Law, San Francisco
Downloads 392 (130,903)
Citation 1

Abstract:

Loading...

24.

The Sound and Fury of Patent Activity

Stanford Law and Economics Olin Working Paper No. 521, Stanford Public Law Working Paper, UC Hastings Research Paper No. 290, 103 Minnesota Law Review 1793 (2019)
Number of pages: 100 Posted: 14 Jun 2018 Last Revised: 17 Apr 2020
Robin Feldman and Mark A. Lemley
UC Law, San Francisco and Stanford Law School
Downloads 388 (132,407)

Abstract:

Loading...

25.

The Devil in the Tiers

UC Hastings Research Paper No. 379, Oxford J. L. & Biosci.
Number of pages: 58 Posted: 05 Dec 2019 Last Revised: 27 Jan 2021
Robin Feldman
UC Law, San Francisco
Downloads 369 (140,049)
Citation 1

Abstract:

Loading...

drug prices, formulary, healthcare, tier system, incentive, insurers, list price, rebate schemes

26.

Startups and Unmet Legal Needs

Utah Law Review, No. 4, 2016
Number of pages: 19 Posted: 11 Jul 2015 Last Revised: 01 Sep 2016
UC Law, San Francisco, University of California Hastings College of the Law, UC Law, San Francisco and UC Law, San Francisco
Downloads 354 (146,590)
Citation 1

Abstract:

Loading...

legal needs, startups, entrepreneurs, incorporation, employment contracts, intellectual property, immigration, technology

27.

Competition at the Dawn of Artificial Intelligence

Journal of Antitrust Enforcement, Forthcoming, UC Hastings Research Paper No. 298
Number of pages: 22 Posted: 13 Aug 2018 Last Revised: 09 Nov 2023
Robin Feldman and Nick Thieme
UC Law, San Francisco and UC Law, San Francisco
Downloads 348 (149,285)

Abstract:

Loading...

Artificial Intelligence

28.

Considerations on the Emerging Implementation of Biometric Technology

Number of pages: 28 Posted: 03 Feb 2004
Robin Feldman
UC Law, San Francisco
Downloads 343 (151,628)

Abstract:

Loading...

Biometrics, immigration, airport security, intellectual property, points of entry, terrorism

29.

Open Source, Open Access, and Open Transfer: Market Approaches to Research Bottlenecks

Northwestern Journal of Technology and Intellectual Property, 2008
Number of pages: 28 Posted: 02 May 2008
Robin Feldman and Kristopher A. Nelson
UC Law, San Francisco and University of California, San Diego (UCSD), Students
Downloads 287 (183,098)
Citation 1

Abstract:

Loading...

patent, patent thicket, research, bottleneck, open source, biomedical, biotechnology, biotech, medical, antitrust

30.

Patent Demands and Initial Public Offerings

19 Stan. Tech. L. Rev. 52 (2015), UC Hastings Research Paper No. 140
Number of pages: 41 Posted: 09 Apr 2015 Last Revised: 25 Feb 2016
Robin Feldman and Evan Frondorf
UC Law, San Francisco and University of California Hastings College of the Law
Downloads 285 (184,397)
Citation 2

Abstract:

Loading...

patent demands, initial public offerings, patent assertion

31.

Is Patent Enforcement Efficient?

98 Boston University Law Review 649 (2018), Stanford Public Law Working Paper, Stanford Law and Economics Olin Working Paper No. 518, UC Hastings Research Paper No. 277
Number of pages: 21 Posted: 08 Mar 2018 Last Revised: 17 Apr 2020
Mark A. Lemley and Robin Feldman
Stanford Law School and UC Law, San Francisco
Downloads 274 (191,963)
Citation 2

Abstract:

Loading...

32.

Historic Perspectives on Law & Science

Stanford Technology Law Review, p. 1, 2009
Number of pages: 18 Posted: 28 Dec 2010
Robin Feldman
UC Law, San Francisco
Downloads 247 (212,758)

Abstract:

Loading...

law and society, Law & Society, history, law and science, law & Science, intellectual property, patent, copyright, trademark

33.

Law's Misguided Love Affair with Science

Minnesota Journal of Law, Science & Technology, 2009
Number of pages: 21 Posted: 02 May 2008
Robin Feldman
UC Law, San Francisco
Downloads 247 (212,758)
Citation 1

Abstract:

Loading...

science, jurisprudence, history, society, legal realism, langdell, legal process, critical legal studies, law and economics, history

34.

Naked Price and Pharmaceutical Trade Secret Overreach

22 Yale J. L. & Tech. 61 (2020), UC Hastings Research Paper No. 354
Number of pages: 68 Posted: 26 Jul 2019 Last Revised: 06 Oct 2020
Robin Feldman and Charles Graves
UC Law, San Francisco and UC Law, San Francisco
Downloads 241 (217,894)

Abstract:

Loading...

trade secret, pharmacy benefit manager, PBM, pharmaceutical, intellectual property

35.

The CRISPR Revolution: What Editing Human DNA Reveals About the Patent System's DNA

Robin Feldman, The CRISPR Revolution: What Editing Human DNA Reveals About the Patent System’s DNA, 64 UCLA L. Rev. Disc. 392 (2016).
Number of pages: 19 Posted: 30 Jul 2016 Last Revised: 10 Nov 2016
Robin Feldman
UC Law, San Francisco
Downloads 231 (227,143)
Citation 2

Abstract:

Loading...

patents, CRISPR, gene editing, commercialization, technology, patent system

36.

Database from Empirical Evidence of Drug Pricing Games - A Citizen's Pathway Gone Astray

Stanford Technology Law Review, Forthcoming
Number of pages: 688 Posted: 07 Mar 2017
UC Law, San Francisco, University of California Hastings College of the Law, UC Law, San Francisco and University of California, Hastings College of the Law, Students
Downloads 188 (274,505)

Abstract:

Loading...

patent, pharmaceutical, pharmaceuticals, citizen petitions, Hatch-Waxman, FDA, drug prices, antitrust, drug pricing, health, data, dataset, data set, database

37.

Rethinking Rights in Biospace

Southern California Law Review, Vol. 79, No. 1, 2005
Number of pages: 44 Posted: 18 Feb 2005
Robin Feldman
UC Law, San Francisco
Downloads 188 (274,505)

Abstract:

Loading...

biotech, biotechnology, gene, genes, inherency, written description,enablement,patent

38.

Understanding and Incentivizing Biosimilars

64 Hastings Law Journal 57, UC Hastings Research Paper No. 22
Number of pages: 28 Posted: 24 Feb 2013
Jason Kanter and Robin Feldman
University of California Hastings College of the Law and UC Law, San Francisco
Downloads 185 (278,281)

Abstract:

Loading...

39.

Defensive Leveraging in Antitrust

Georgetown Law Journal, Vol. 87, June 1999
Number of pages: 40 Posted: 08 Sep 1999 Last Revised: 19 Feb 2016
Robin Feldman
UC Law, San Francisco
Downloads 181 (283,760)

Abstract:

Loading...

40.

Captive Generics: The Wolf in Sheep's Clothing

UC Hastings Research Paper No. 416, Harvard Journal on Legislation, Vol. 59, No. 383, 2022
Number of pages: 45 Posted: 22 Jul 2021 Last Revised: 06 Sep 2022
Robin Feldman
UC Law, San Francisco
Downloads 172 (296,773)
Citation 1

Abstract:

Loading...

generics, pharmaceutical, captive generics, competition, Hatch-Waxman, generics industry

41.

The Inventor's Contribution

UCLA Journal of Law & Technology, Vol. 6, 2005
Number of pages: 52 Posted: 26 Apr 2005
Robin Feldman
UC Law, San Francisco
Downloads 168 (302,622)

Abstract:

Loading...

Patent, biotech, biotechnology, written description, Lilly, enablement

42.

The Role of the Subconscious in Intellectual Property Law

Hastings Science & Technology Law Journal, Vol. 2, p. 1, 2010
Number of pages: 25 Posted: 25 May 2010
Robin Feldman
UC Law, San Francisco
Downloads 166 (305,770)

Abstract:

Loading...

inequitable conduct, intellectual property, patent, trade secret, copyright

43.

Rewarding Failure with Patents

Yale Journal of Health Policy, Law, and Ethics, Forthcoming, UC Hastings Research Paper Forthcoming
Number of pages: 55 Posted: 21 Sep 2022
Robin Feldman
UC Law, San Francisco
Downloads 164 (308,949)

Abstract:

Loading...

Pharmaceuticals, Innovation, Patents, Anticompetitive

44.

Pharmaceutical 'Pay-for-Delay' Reexamined: A Dwindling Practice or a Persistent Problem?

71 Hastings L. J. 959 (2020), UC Hastings Research Paper No. 368
Number of pages: 16 Posted: 03 Oct 2019 Last Revised: 21 Oct 2020
Laura Karas, Gerard F. Anderson and Robin Feldman
Harvard University, Law School, Johns Hopkins University - Department of Health Policy and Management and UC Law, San Francisco
Downloads 158 (320,570)

Abstract:

Loading...

anticompetitive, pay-for-delay, patent settlement, reverse payment

45.

Trade Secrets in Biologic Medicine: The Boundary with Patents

Columbia Science and Technology Law Review, Forthcoming, UC Hastings Research Paper Forthcoming
Number of pages: 54 Posted: 03 Oct 2022 Last Revised: 30 Nov 2022
Robin Feldman
UC Law, San Francisco
Downloads 157 (320,570)

Abstract:

Loading...

trade secrets, biologics, pharmaceuticals, drugs, medicine, patents, innovation

46.

The Fatal Attraction of Pay-for-Delay

18 Chi.-Kent J. Intell. Prop. 249 (2019), UC Hastings Research Paper No. 313
Number of pages: 37 Posted: 25 Jan 2019 Last Revised: 21 Oct 2020
Robin Feldman and Prianka Misra
UC Law, San Francisco and University of California Hastings College of the Law
Downloads 155 (324,046)
Citation 1

Abstract:

Loading...

pharmaceutical industry, pay-for-delay, brand-name drug, drugs, generic, drug companies, reverse payment settlements, competition, Hatch-Waxman Act, brand-generic settlements

47.

Pharmaceutical Pipeline Divestitures Study: Preliminary Results

UC Hastings Research Paper Forthcoming
Number of pages: 7 Posted: 18 Jun 2021 Last Revised: 01 Jul 2021
Robin Feldman
UC Law, San Francisco
Downloads 149 (334,809)

Abstract:

Loading...

Pharmaceutical, Mergers, FTC, Pipeline, Divestitures, Competition

48.

Plain Language Patents

Texas Intellectual Property Law Journal, Vol. 17, p. 289, 2009
Number of pages: 17 Posted: 28 Dec 2010
Robin Feldman
UC Law, San Francisco
Downloads 142 (347,916)

Abstract:

Loading...

patent, patents, plain language, language, legal theory, legal reasoning, expert courts, federal circuit, intellectual property

49.

Transparency

19 Virginia Journal of Law and Technology 271 (2014), UC Hastings Research Paper No. 98
Number of pages: 53 Posted: 01 Mar 2014 Last Revised: 19 Feb 2016
Robin Feldman
UC Law, San Francisco
Downloads 140 (351,791)

Abstract:

Loading...

50.

AI Governance in the Financial Industry

Stanford Journal of Law, Business, and Finance, Vol. 27, No. 1, 2022, UC Hastings Research Paper Forthcoming
Number of pages: 39 Posted: 10 Oct 2022
Robin Feldman and Kara Stein
UC Law, San Francisco and Public Company Oversight Board
Downloads 137 (357,714)

Abstract:

Loading...

Artificial Intelligence, Regulation, Financial Industry

51.

Ending Patent Exceptionalism & Structuring the Rule of Reason: The Supreme Court Opens the Door for Both

Minnesota Journal of Law, Science & Technology, Vol. 15, No.1, 2014, UC Hastings Research Paper No. 70
Number of pages: 17 Posted: 30 Sep 2013 Last Revised: 25 Apr 2014
Robin Feldman
UC Law, San Francisco
Downloads 137 (357,714)
Citation 2

Abstract:

Loading...

reverse payments, patents, Hatch-Waxman, pay-for-delay, pharmaceutical, generic, patent trolls

52.

Copyright at the Bedside: Should We Stop the Spread?

Stanford Technology Law Review, Vol. 16, No. 3, p. 623, Spring 2013, UC Hastings Research Paper No. 51
Number of pages: 34 Posted: 01 Apr 2013 Last Revised: 05 Aug 2013
Robin Feldman and John Newman
UC Law, San Francisco and University of California, San Francisco (UCSF)
Downloads 134 (363,862)

Abstract:

Loading...

copyright, standards, MMSE, cognitive testing, health care, intellectual property

53.

The Intellectual Property Landscape for IPS Cells

Stanford Journal of Law Science & Policy, Vol. 3, p. 17, 2010
Number of pages: 20 Posted: 28 Dec 2010
Robin Feldman and Deborah Furth
UC Law, San Francisco and affiliation not provided to SSRN
Downloads 125 (383,630)

Abstract:

Loading...

patent, stem cells, iPS cells, biotechnology, life science, life sciences, law and science, law & science

54.

Empirical Evidence of Drug Companies Using Citizen Petitions to Hold Off Competition

UC Hastings Research Paper No. 269
Number of pages: 13 Posted: 14 Feb 2018 Last Revised: 04 Mar 2018
Robin Feldman, John Gray and Giora Ashkenazi
UC Law, San Francisco, UC Law, San Francisco and UC Law, San Francisco
Downloads 119 (397,889)

Abstract:

Loading...

55.

The Gender Gap in Startup Catalyst Organizations: Bridging the Divide between Narrative and Reality

Oregon Law Review, Forthcoming
Number of pages: 24 Posted: 06 Oct 2016
Robin Feldman, Alice Armitage and Connie Wang
UC Law, San Francisco, UC Law, San Francisco and University of California, Hastings College of the Law, Students
Downloads 119 (397,889)

Abstract:

Loading...

Startups, Catalysts, Co-Working Spaces, Incubators, Accelerators, Gender, Women, Entrepreneurship, Technology

56.

Learning from Past Mistakes — The US Patent System and International Trade Agreements

Working Paper, East-West Center Workshop on Mega-Regionalism - New Challenges for Trade and Innovation
Number of pages: 11 Posted: 07 Mar 2016
Robin Feldman
UC Law, San Francisco
Downloads 112 (415,839)
Citation 1

Abstract:

Loading...

57.

The Cancer Curse: Regulatory Failure by Success

21 Col. Sci. & Tech. L. Rev. 1 (2019), UC Hastings Research Paper No. 353
Number of pages: 37 Posted: 19 Sep 2019 Last Revised: 06 Oct 2020
Robin Feldman
UC Law, San Francisco
Downloads 111 (418,589)
Citation 1

Abstract:

Loading...

cancer, regulatory failure, regulation, social policy, unintended regulatory success

58.

Lochner Revenant: The Dormant Commerce Clause & Extraterritoriality

NYU Journal of Law & Liberty, Vol. 16, No. 2, 2022
Number of pages: 99 Posted: 03 Oct 2022 Last Revised: 15 Feb 2023
Robin Feldman and Gideon Schor
UC Law, San Francisco and UC Law, San Francisco
Downloads 105 (435,523)

Abstract:

Loading...

dormant commerce clause, federalism, extraterritoriality, protectionism, state sovereignty

59.

Patents as Property for the Takings

NYU Journal of Intellectual Property & Entertainment Law, Forthcoming, UC Hastings Research Paper Forthcoming
Number of pages: 68 Posted: 09 Apr 2022
Robin Feldman
UC Law, San Francisco
Downloads 102 (444,648)

Abstract:

Loading...

patents, pharmaceuticals, innovation, takings, fifth amendment, private property

60.

Assessing Strategies to Delay Generic Drug Entry

NYU Journal of Intellectual Property & Entertainment Law, 11, UC Hastings Research Paper Forthcoming, NYU School of Law, Public Law Research Paper No. 22-04
Number of pages: 21 Posted: 18 Nov 2021 Last Revised: 11 Mar 2022
New York University School of Law, UC Law, San Francisco, Kirkland & Ellis, Independent and United States District Court for the District of Massachusetts
Downloads 100 (450,834)

Abstract:

Loading...

Symposium, Access, Medicine, COVID, Coronavirus, NYU, Prescription, Drugs, Government, Healthcare, Insurance, Research, Pharmaceutical, Pharma, NIH, Pandemic, Vaccine, Patent, Generic, Pay-For-Delay, Reverse-Payment, Settlement, Intellectual Property, IP, Licensing, Public Health, Biomedical, Bioeth

61.

Federalism, First Amendment & Patents: The Fraud Fallacy

17 Columbia Science and Technology Law Review 30 (2015)
Number of pages: 60 Posted: 11 Jun 2015 Last Revised: 18 Feb 2016
Robin Feldman
UC Law, San Francisco
Downloads 98 (456,789)
Citation 1

Abstract:

Loading...

preemption, patent assertion, federalism, antitrust, First Amendment, fraud

62.

Book Review of Pharma: Greed, Lies, and the Poisoning of America

Governance: An International Journal of Policy, Administration, and Institutions, Forthcoming
Number of pages: 5 Posted: 17 Mar 2021
Robin Feldman
UC Law, San Francisco
Downloads 95 (466,206)

Abstract:

Loading...

Pharma

63.

Leading with the Trailing Edge: Facilitating Patient Choice for Insulin Products

UC San Francisco Research Paper No. Forthcoming
Number of pages: 45 Posted: 06 Mar 2023 Last Revised: 23 May 2023
Robin Feldman
UC Law, San Francisco
Downloads 92 (475,986)

Abstract:

Loading...

Insulin, Trailing Edge, Medicare, Medicare Part D, Patients, Patents, Pharmaceuticals, Drug Prices, Drug Pricing, Follow-On, FDA, Medicines, Biologics, Generics, Biosimilars, Analog, Affordability

64.

Purple is the New Orange

University of Illinois Law Review, Forthcoming
Number of pages: 58 Posted: 27 Apr 2023
Robin Feldman
UC Law, San Francisco
Downloads 91 (479,304)

Abstract:

Loading...

Biologics, Pharmaceuticals, Insulin, Biosimilars, Intellectual Property, Hatch-Waxman, Orange Book, Purple Book, Patents, Biosimilars, Generics, Drugs

65.

Federalism, Patents, and the Constitutionality of State Pharmaceutical Regulation

UC Hastings Research Paper No. 311
Number of pages: 14 Posted: 15 Nov 2018 Last Revised: 08 Dec 2018
UC Law, San Francisco, UC Law, San Francisco, University of California - Institute for Innovation Law, UCSF/UC Hastings Consortium on Law, Science & Health Policy and UCSF/UC Hastings Consortium on Law, Science & Health Policy
Downloads 88 (489,282)

Abstract:

Loading...

pharmaceutical, drug pricing, constitutionality, federalism, preemption, Takings Clause, patent law, Fifth Amendment

66.

Designing Disruption in Pharmaceuticals

UC Hastings Research Paper Forthcoming
Number of pages: 39 Posted: 17 Sep 2021
Robin Feldman
UC Law, San Francisco
Downloads 86 (496,268)

Abstract:

Loading...

67.

A Conversation on Judicial Decision-Making

UC Hastings Research Paper No. 28
Number of pages: 33 Posted: 11 Aug 2012 Last Revised: 25 May 2014
Robin Feldman
UC Law, San Francisco
Downloads 86 (496,268)
Citation 5

Abstract:

Loading...

intellectual property, patents, supreme court, federal circuit

68.

Advertising Medicine: Selling the Cure

26 STAN. TECH. L. REV. 1 (2023)
Number of pages: 48 Posted: 03 Oct 2022 Last Revised: 16 Feb 2023
Robin Feldman
UC Law, San Francisco
Downloads 77 (530,043)

Abstract:

Loading...

advertising, medicine, pharmaceuticals, FTC, FDA, direct-to-consumer

69.

Viral Licensing: Ensuring the Public Interest When Taxpayers Fund Pharmaceutical Research

Santa Clara Law Review, Vol. 59, No. 3, 2020, UC Hastings Research Paper No. 324
Number of pages: 51 Posted: 17 Dec 2018 Last Revised: 21 Oct 2020
Robin Feldman, Betty Chang Rowe and Rabiah Oral
UC Law, San Francisco, UC Law, San Francisco and University of California - Institute for Innovation Law
Downloads 67 (572,273)

Abstract:

Loading...

pharmaceutical, policy, drug development system, universities, funding, innovation

70.

Incentivizing Failure

UC Hastings Research Paper No. 415
Number of pages: 40 Posted: 23 Jul 2021 Last Revised: 06 Sep 2022
Robin Feldman
UC Law, San Francisco
Downloads 65 (581,335)

Abstract:

Loading...

Patent, Incentives, Pharmaceutical, Drug, Failure

71.

The Burden on Society from Eleventh-Hour 'Citizen Petitions' Filed to Slow Generic Drugs

79 Md. L. Rev. Online 1 (2020), UC Hastings Research Paper No. 355
Number of pages: 16 Posted: 20 Jun 2019 Last Revised: 21 Oct 2020
Robin Feldman
UC Law, San Francisco
Downloads 50 (658,271)

Abstract:

Loading...

citizen petitions, FDA, cost to society, prescription drugs

72.

Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation

Journal of Health Politics, Policy and Law, Vol. 47, No. 5, 2022: 583-607. doi: https://doi.org/10.1215/03616878-9978131, UC Hastings Research Paper Forthcoming
Number of pages: 25 Posted: 05 Oct 2022
UC Law, San Francisco, University of California, Berkeley, University of California, Los Angeles (UCLA) and University of California, Berkeley
Downloads 45 (688,292)

Abstract:

Loading...

Herfindahl-Hirschman Index, pharmaceutical industry, Federal Trade Commission, FTC, consolidation, mergers and acquisitions

73.

Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation

Hastings International and Comparative Law Review, Vol. 42, No. 2, 2019
Number of pages: 33 Posted: 09 May 2023
Harvard University, Law School, UC Law, San Francisco, Johns Hopkins University - Carey Business School, Johns Hopkins University - Bloomberg School of Public Health and Johns Hopkins University - Department of Health Policy and Management
Downloads 41 (714,118)

Abstract:

Loading...

Pharmaceutical industry, patient advocacy groups, Physician Payments Sunshine Act, disclosure, regulation

74.

Dance of the Biologics

Berkeley Technology Law Journal, Forthcoming
Number of pages: 63 Posted: 09 Nov 2023
Robin Feldman
UC Law, San Francisco
Downloads 19 (891,292)

Abstract:

Loading...